Journal
ADVANCED HEALTHCARE MATERIALS
Volume -, Issue -, Pages -Publisher
WILEY
DOI: 10.1002/adhm.202301683
Keywords
diabetic wound healing; panthenol citrate; provitamin B-5; regenerative engineering and medicine
Ask authors/readers for more resources
Impaired wound healing is a common complication for diabetic patients. A novel compound called panthenol citrate (PC) has been developed to address this issue. PC has various properties that promote wound healing and has shown positive effects in diabetic rodent models, improving re-epithelialization, tissue formation, and reducing inflammation and oxidative stress.
Impaired wound healing is a common complication for diabetic patients and effective diabetic wound management remains a clinical challenge. Furthermore, a significant problem that contributes to patient morbidity is the suboptimal quality of healed skin, which often leads to reoccurring chronic skin wounds. Herein, a novel compound and biomaterial building block, panthenol citrate (PC), is developed. It has interesting fluorescence and absorbance properties, and it is shown that PC can be used in soluble form as a wash solution and as a hydrogel dressing to address impaired wound healing in diabetes. PC exhibits antioxidant, antibacterial, anti-inflammatory, and pro-angiogenic properties, and promotes keratinocyte and dermal fibroblast migration and proliferation. When applied in a splinted excisional wound diabetic rodent model, PC improves re-epithelialization, granulation tissue formation, and neovascularization. It also reduces inflammation and oxidative stress in the wound environment. Most importantly, it improves the regenerated tissue quality with enhanced mechanical strength and electrical properties. Therefore, PC could potentially improve wound care management for diabetic patients and play a beneficial role in other tissue regeneration applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available